Answers are grounded in this paper and cite their sources.
When given in addition to a RAS inhibitor, finerenone reduced albuminuria without adverse effects on serum potassium levels or renal function in Japanese patients with T2DM and DN.
No takes yet. Share an insight, caveat, or question.
Katayama et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: